Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| OncoMed Pharmaceuticals Inc | 100,000 | reported | 04 Jan 2018 | tx 24+504,500−45,164 |
| OmniAb, Inc. | 40,000 | reported | 23 Jun 2023 | tx 15+458,971 |
| LIGAND PHARMACEUTICALS INC | 0 | reported | 01 Nov 2022 | tx 62+165,321−79,227 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Jun 2023 | GRANT_AWARD | OmniAb, Inc. | 40,000 | 0.00 USD | deriv |
| 23 Jun 2023 | GRANT_AWARD | OmniAb, Inc. | 20,000 | 0.00 USD | deriv |
| 30 Jan 2023 | GRANT_AWARD | OmniAb, Inc. | 8,753 | 0.00 USD | |
| 30 Jan 2023 | GRANT_AWARD | OmniAb, Inc. | 37,840 | 0.00 USD | deriv |
| 09 Nov 2022 | PURCHASE | OmniAb, Inc. | 43,000 | 2.77 USD | first after silence |
| 01 Nov 2022 | GRANT_AWARD | OmniAb, Inc. | 172,512 | — | |
| 01 Nov 2022 | GRANT_AWARD | OmniAb, Inc. | 10,513 | — | deriv |
| 01 Nov 2022 | GRANT_AWARD | OmniAb, Inc. | 37,840 | — | deriv |
| 01 Nov 2022 | GRANT_AWARD | OmniAb, Inc. | 13,994 | — | deriv |
| 01 Nov 2022 | GRANT_AWARD | OmniAb, Inc. | 14,178 | — | deriv |
| 01 Nov 2022 | GRANT_AWARD | OmniAb, Inc. | 11,789 | — | deriv |
| 01 Nov 2022 | GRANT_AWARD | OmniAb, Inc. | 9,970 | — | deriv |
| 01 Nov 2022 | GRANT_AWARD | OmniAb, Inc. | 10,590 | — | deriv |
| 01 Nov 2022 | GRANT_AWARD | OmniAb, Inc. | 17,427 | — | deriv |
| 01 Nov 2022 | GRANT_AWARD | OmniAb, Inc. | 10,565 | — | deriv |
| 01 Nov 2022 | OTHER | LIGAND PHARMACEUTICALS INC | 1,004 | — | |
| 01 Nov 2022 | OTHER | LIGAND PHARMACEUTICALS INC | 4,340 | — | deriv |
| 10 Jun 2022 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 1,004 | 0.00 USD | |
| 10 Jun 2022 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 4,340 | 0.00 USD | deriv |
| 04 Jun 2021 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 630 | 0.00 USD | |
| 04 Jun 2021 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 3,269 | 0.00 USD | deriv |
| 02 Nov 2020 | PURCHASE | LIGAND PHARMACEUTICALS INC | 1,000 | 82.52 USD | first after silence |
| 10 Jun 2020 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 831 | 0.00 USD | |
| 10 Jun 2020 | GRANT_AWARD | LIGAND PHARMACEUTICALS INC | 2,468 | 0.00 USD | deriv |
| 02 Aug 2019 | PURCHASE | LIGAND PHARMACEUTICALS INC | 1,000 | 95.98 USD | first after silence |
3 purchases reported after at least 12 months of silence — most recent on 09 Nov 2022.